The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases

被引:0
作者
Niang, U. [1 ]
Kamer, S. [1 ]
Ozsaran, Z. [1 ]
Haydaroglu, A. [1 ]
Kilciksiz, S. [2 ]
机构
[1] Ege Univ, Fac Med, Clin Radiat Oncol, Izmir, Turkey
[2] Gaziantep Univ, Fac Med, Clin Radiat Oncol, Gaziantep, Turkey
来源
JOURNAL OF BUON | 2009年 / 14卷 / 02期
关键词
biphosphonates; bone metastases; pain; palliative radiotherapy; BREAST-CANCER PATIENTS; SKELETAL COMPLICATIONS; ZOLEDRONIC ACID; DOUBLE-BLIND; RADIATION-THERAPY; ORAL CLODRONATE; PLACEBO; PAMIDRONATE; BISPHOSPHONATES; TRIAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The objective of this study was to evaluate the palliation of pain of bone metastases with biphoshonates and different radiotherapy protocols, in 372 cancer patients. Patients and methods: Patients were treated with one of the 3 different radiotherapy protocols: 30 Gy in 10 fractions (group A), 20 Gy in 5 fractions (group B) and 8 Gy in a single fraction (group C). Two patient groups were studied: one with radiotherapy alone and the second with biphosphonates plus radiotherapy. The severity of pain was recorded before treatment. According to the pain relief, two different groups were defined: palliation rate < 50% (limited palliation) and > 50% (partial palliation), including complete pain relief. Results: Overall limited and partial palliation rates were 20.2 and 79.8%, respectively (complete pain palliation 24.2%). In the group treated with both external radiotherapy and biphosphonates, limited and partial palliation rates were 19.5 and 80.4%, respectively (p=0.47). For 244 metastatic lesions treated with palliative radiotherapy alone, limited palliation rate was 20.4% and partial palliation rate 79.5%. No differences were detected between the groups with or without bithosphonates treatment in terms of pain palliation. According to the radiotherapy protocol, limited palliation rates in groups A, B, and C were 17.7, 20.3, and 28.5%, respectively (p=0.19, p=0.38, and p=0.26, respectively). Partial palliation rates were 82.2% in group A, 79.6% in group B and 71.4% in group C (p=0.42, p=0.21, and p=0.11, respectively). Similarly, no statistically significant differences were detected among the 3 radiotherogy schemes in terms of pain palliation. Conclusion: When combined with palliative radiotherapy, biphosphonates did not have any additive effects on pain palliation in the management of painful bone metastases. In addition, a single radiotherapy fraction provides equal pain palliation as multiple fractions.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 35 条
  • [1] Comparative evaluation of two hypofractionated radiotherapy regimens for painful bone metastases
    Amichetti, M
    Orrù, P
    Madeddu, A
    Murtas, R
    Carau, B
    Farigu, R
    Carta, S
    Orru, S
    Nagliati, M
    Lay, G
    Dessì, M
    [J]. TUMORI JOURNAL, 2004, 90 (01): : 91 - 95
  • [2] [Anonymous], COCHRANE DATABASE SY
  • [3] Ashton A, 1999, RADIOTHER ONCOL, V52, P111
  • [4] External beam radiotherapy for painful osseous metastases: Pooled data dose response analysis
    Ben-Josef, E
    Shamsa, F
    Youssef, E
    Porter, AT
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (03): : 715 - 719
  • [5] Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO
  • [6] 2-0
  • [7] Did the pattern of practice in the prescription of palliative radiotherapy for the treatment of uncomplicated bone metastases change between 1999 and 2005 at the Rapid Response Radiotherapy Program?
    Bradley, N. M. E.
    Husted, J.
    Sey, M. S. L.
    Sinclair, E.
    Li, K. K.
    Husain, A. F.
    Danjoux, C.
    Barnes, E. A.
    Tsao, M. N.
    Barbera, L.
    Harris, K.
    Chiu, H.
    Doyle, M.
    Chow, E.
    [J]. CLINICAL ONCOLOGY, 2008, 20 (05) : 327 - 336
  • [8] Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO
  • [9] 2-H
  • [10] CLOHISY DR, 2003, CANCER S, V97, P867